Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

ClinicalTrials.gov ID: NCT01067105

Public ClinicalTrials.gov record NCT01067105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 12:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-Month Open-Label, Long-Term Safety Extension Study of Once Daily Ciclesonide HFA Nasal Aerosol (160 μg) in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

6-month safety extension study in subjects who have completed Study 060-633 (NCT00953147). Evaluating the long-term safety of ciclesonide HFA nasal aerosol 160 μg administered once-daily in patients with Perennial Allergic Rhinitis.

Study identification

NCT ID
NCT01067105
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
824 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2010 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Jun 13, 2012

2010

United States locations

U.S. sites
44
U.S. states
17
U.S. cities
39
Facility City State ZIP Site status
Allergy and Asthma Specialists Group Huntington Beach California 92647 —
California Allergy and Asthma Medical Group Los Angeles California 90025 —
Southern California Research Mission Viejo California 92691 —
CHOC PSF, AMC, Division of Allergy Asthma and Immunology Orange California 92868 —
California Allergy and Asthma Medical Group Palmdale California 93551 —
Allergy Associates Medical Group San Diego California 92120 —
Bensch Research Associates Stockton California 95207 —
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907 —
Storms Clinical Research Institute Colorado Springs Colorado 80907 —
Colorado Allergy and Asthma Centers Denver Colorado 80230 —
DataQuest Medical Research Lawrenceville Georgia 30046 —
Allergy and Asthma Consultants Lilburn Georgia 30047 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
Clinical Research Atlanta Stockbridge Georgia 30342 —
Atlanta Allergy and Asthma Clinic Woodstock Georgia 30188 —
Clinical Research Center of Indiana Indianapolis Indiana 46208 —
GR Bethesda Maryland 20814 —
Northeast Medical Research Associates, Inc. North Dartmouth Massachusetts 02747 —
Respiratory Medicine Research Institute of Michigan Ypsilanti Michigan 48197 —
The Clinical Research Center St Louis Missouri 63141 —
Clinical Research Group of Montana Bozeman Montana 59718 —
Allergy and Asthma Center of NC High Point North Carolina 27262 —
North Carolina Clinical Research Raleigh North Carolina 27607 —
Toledo Center for Clinical Research Sylvania Ohio 43560 —
Allergy and Ashtma Research Group Eugene Oregon 97401 —
Baker Allergy, Asthma, and Dermatology Research Center Lake Oswego Oregon 97035 —
Allergy Associates Research Center Portland Oregon 977213 —
Valley Clinical Research Bethlehem Pennsylvania 18020 —
Asthma and Allergy Research Upland Pennsylvania 19013 —
Asthma, Nasal Disease, and Allergy Research Center of New England Providence Rhode Island 02906 —
National Allergy, Asthma, and Urticaria Centers Charleston South Carolina 29406 —
ISIS Clinical Research Austin Texas 78731 —
Sirius Clinical Research Austin Texas 78759 —
TTS Research Boerne Texas 78006 —
Pharmaceutical Research and Consulting Dallas Texas 75231 —
North Texas Institute for Clinical Trials Fort Worth Texas 76132 —
Allergy and Asthma Associates Houston Texas 77054 —
Kerrville Research Associates Kerrville Texas 78028 —
Central Texas Health Research New Braunfels Texas 78130 —
Western Sky Medical Research Paso Texas 79903 —
Biogenics Research Institute San Antonio Texas 78229 —
Southwest Allergy and Asthma Center San Antonio Texas 78229 —
Sylvana Research San Antonio Texas 78229 —
ASTHMA Inc. Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01067105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2012 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01067105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →